Recruiting at 1 site No phase Diabetes Type 2

Diabetes Type 2 study: CGM Device

Official title Enhancing Digitally Delivered Diabetes Education With Real-Time CGM

ClinicalTrials.gov ID: NCT06296550

What this study is testing

What it's testing
This study aims to find out if using a continuous glucose monitor along with text message education improves health outcomes for people with type 2 diabetes.
Who it's for
The study is looking for people with type 2 diabetes who do not use insulin.
What's involved
Participants will use a continuous glucose monitor and receive diabetes education through text messages for six months.
Time commitment
The study lasts for six months and involves using the monitoring device and engaging with the text message program.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Diagnosed with type 2 diabetes
  • Are not currently using a CGM
  • Are not using insulin therapies
  • Speak English, Spanish or Arabic
  • Have A1c between 7.5% and 12.0% in last 90 days

You likely can't join if

  • Are using insulin therapies
  • Are pregnant
  • Are currently using a CGM
  • Are currently participating in another diabetes-related study
See the full eligibility criteria
Who can join
  • Diagnosed with type 2 diabetes
  • Are not currently using a CGM
  • Are not using insulin therapies
  • Speak English, Spanish or Arabic
  • Have A1c between 7.5% and 12.0% in last 90 days
  • Have a cellphone that can receive/send text messages and counts steps
What rules you out
  • Are using insulin therapies
  • Are pregnant
  • Are currently using a CGM
  • Are currently participating in another diabetes-related study

The study team makes the final eligibility decision.

Where it is enrolling

  • San Diego, California, United States

Compensation & support

This study's listing mentions compensation or reimbursement.

No amount is published here because ClinicalTrials.gov has no reliable field for payment or travel support. Ask the study team what's actually covered (payment for your time, travel, parking, or other study costs), and never join a trial for the compensation alone.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team, so confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at San Diego, California, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.